Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy [7]

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2410-2411

  Fyfe, Gwendolyn A ^a   Fisher, Richard I ^a   Rosenberg, Steven A ^a   Sznol, Mario ^a   Parkinson, David R ^a   Louie, Arthur C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; LETTER; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0029812542     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2410     Document Type: Letter

References (0)